<DOC>
	<DOCNO>NCT01450579</DOCNO>
	<brief_summary>This trial investigate clinically recommend dosage ASP7373 base comparison immunogenicity safety among three dos ASP7373 healthy adult .</brief_summary>
	<brief_title>A Study Evaluate Immune Response ASP7373 Its Safety Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<criteria>Body weight : Female : ≥40.0 kg , &lt; 70.0 kg , Male : ≥50.0 kg , &lt; 80.0 kg BMI : ≥17.6 , &lt; 26.4 Healthy , judge investigator subinvestigator base result physical examination ( subjective symptom objective finding ) test obtain Scheduled receive another vaccine study period History H5 influenza infection receive H5 influenza vaccine Past history anaphylactic shock allergic reaction generalize eruption due food drug ( include vaccine ) allergy , fever ≥ 39.0°C within 2 day previous vaccination ( influenza vaccine others ) Diagnosis immune deficit past , family member ( within third degree kinship ) diagnosis congenital immunodeficiency syndrome Received schedule receive live vaccine within 28 day prior vaccination study vaccine , receive schedule receive inactivate vaccine toxoid within 7 day prior vaccination study vaccine History seizure Female subject breastfeed , pregnant , possibly pregnant , plan become pregnant study period</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Recombinant Influenza HA vaccine</keyword>
	<keyword>Immunogenicity ASP7373</keyword>
</DOC>